Pideka Group (Pideka Group) Equity-to-Asset : 0.56 (As of Sep. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pideka Group's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $23.85 Mil. Pideka Group's Total Assets for the quarter that ended in Sep. 2021 was $42.80 Mil. Therefore, Pideka Group's Equity to Asset Ratio for the quarter that ended in Sep. 2021 was 0.56.

The historical rank and industry rank for Pideka Group's Equity-to-Asset or its related term are showing as below:

CIMVF's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

Pideka Group Equity-to-Asset Historical Data

The historical data trend for Pideka Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Equity-to-Asset Chart

Pideka Group Annual Data

Trend

Equity-to-Asset

Pideka Group Quarterly Data
	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21
Equity-to-Asset	Get a 7-Day Free Trial			-	-	0.39	0.59	0.56

Competitive Comparison of Pideka Group's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pideka Group's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pideka Group's Equity-to-Asset falls into.

Pideka Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pideka Group's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Pideka Group's Equity to Asset Ratio for the quarter that ended in Sep. 2021 is calculated as

Equity to Asset (Q: Sep. 2021 )	=	Total Stockholders Equity	/	Total Assets
	=	23.851	/	42.797
	=	0.56

Pideka Group (OTCPK:CIMVF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Pideka Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pideka Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pideka Group (Pideka Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2

Website

https://www.ikanikfarms.com

Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.